Business
HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference ...
About this update from Hls Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\n HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n\n\n\n\n HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference\n \n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n April 28, 2025\n \n\n /CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that\n \n Brian Walsh\n \n , Chief Commercial Officer, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference, which takes place\n \n May 5-6, 2025\n \n at the Metro Toronto Convention Centre, in downtown\n \n Toronto\n \n .\n \n\n Details on the Company's presentation are as follows:\n \n\n\n\n\n\n\n\n Date\n \n :\n \n\n\n\n\n\n Monday, May 5, 2025\n \n\n\n\n\n\n\n\n\n Time\n \n :\n \n\n\n\n\n\n 2:30 p.m. Eastern Time\n \n\n\n\n\n\n\n\n\n Webcast\n \n :\n \n\n\n\n\n\n\n https://event.summitcast.com/view/hG2KhRan38C8o5wZiWyxNK/Cp3bEUQHmtKN2vW4TPGJas\n \n\n\n\n\n\n\n\n Webcast and replay information for this event will also be available on the\n \n Event Page\n \n in the Investor Relations section of HLS's website. The replay will be available for 90 days.\n \n\n\n ABOUT HLS THERAPEUTICS INC.\n \n\n\n Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting unmet needs in the treatment of psychiatric disorders and cardiovascular disease. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record ...